455 related articles for article (PubMed ID: 15978827)
41. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
[TBL] [Abstract][Full Text] [Related]
42. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation.
Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G
Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297
[TBL] [Abstract][Full Text] [Related]
43. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
44. [Renal transplantation and malignancies: A single-centre experience (25 years)].
Stefoni S; Scolari MP; Sestigiani E; Faenza A; Campieri C; Buscaroli A; Liviano D'Arcangelo G; D'Addio F
G Ital Nefrol; 2002; 19(6):650-7. PubMed ID: 12508170
[TBL] [Abstract][Full Text] [Related]
45. Malignancies after renal transplantation in southern Taiwan: experience in one centre.
Feng WW; Wang TN; Chen HC; Ho JC; Ko YC
BJU Int; 2007 Apr; 99(4):825-9. PubMed ID: 17155978
[TBL] [Abstract][Full Text] [Related]
46. Acquired renal cystic disease and renal cell carcinoma in an allograft kidney.
Williams JC; Merguerian PA; Schned AR; Morrison PM
J Urol; 1995 Feb; 153(2):395-6. PubMed ID: 7815595
[TBL] [Abstract][Full Text] [Related]
47. Seroprevalence of human herpes virus-8 in renal transplant recipients: a single center study from Iran.
Ahmadpoor P; Ilkhanizadeh B; Sharifzadeh P; Makhdoomi K; Ghafari A; Nahali A; Yekta Z; Noroozinia F
Transplant Proc; 2007 May; 39(4):1000-2. PubMed ID: 17524874
[TBL] [Abstract][Full Text] [Related]
48. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States.
Schold JD; Rehman S; Kayle LK; Magliocca J; Srinivas TR; Meier-Kriesche HU
Transpl Int; 2009 Jun; 22(6):626-34. PubMed ID: 19207187
[TBL] [Abstract][Full Text] [Related]
49. Malignancy after kidney transplantation: results of 400 patients from a single center.
Stratta P; Morellini V; Musetti C; Turello E; Palmieri D; Lazzarich E; Cena T; Magnani C
Clin Transplant; 2008; 22(4):424-7. PubMed ID: 18312442
[TBL] [Abstract][Full Text] [Related]
50. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
51. [Herpetic viruses and renal transplantation].
Morrone LF; Capurso D; D'Elia F; Di Paolo S; Grandaliano G; Marangi AL; Schena A; Stallone G; Tarantino G;
G Ital Nefrol; 2002; 19(3):316-25. PubMed ID: 12195400
[TBL] [Abstract][Full Text] [Related]
52. [Medical care of renal transplant recipients after the first year post-transplantation].
de Seigneux S; Hadaya K
Rev Med Suisse; 2008 Mar; 4(147):596-8, 600-1. PubMed ID: 18402018
[TBL] [Abstract][Full Text] [Related]
53. Malignancy following renal transplantation.
Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
[TBL] [Abstract][Full Text] [Related]
54. Urological malignancy after renal transplantation.
Besarani D; Cranston D
BJU Int; 2007 Sep; 100(3):502-5. PubMed ID: 17669141
[TBL] [Abstract][Full Text] [Related]
55. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
56. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
[TBL] [Abstract][Full Text] [Related]
57. [Neoplasm prevalence in renal transplantation].
Gómez dos Santos V; Burgos Revilla FJ; Pascual Santos J; Orofino Ascunce L; Fernández-Juárez G; Crespo Martínez L; Clemente Ramos L; Carrera Puerta C; Marcen Letosa R; Escudero Barrilero A; Ortuño Mirete J
Arch Esp Urol; 1997 Apr; 50(3):267-73; discussion 273-4. PubMed ID: 9265450
[TBL] [Abstract][Full Text] [Related]
58. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study.
Alméras C; Foulongne V; Garrigue V; Szwarc I; Vetromile F; Segondy M; Mourad G
Transplantation; 2008 Apr; 85(8):1099-104. PubMed ID: 18431228
[TBL] [Abstract][Full Text] [Related]
59. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis.
Arness T; Pedersen R; Dierkhising R; Kremers W; Patel R
Transpl Infect Dis; 2008 Jul; 10(4):260-8. PubMed ID: 18086277
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr viral infection in renal allograft recipients: a single center experience.
Zadeh ZR; Makhdumi K; Lak SS
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):351-4. PubMed ID: 16970255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
